查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600609

临床试验设备和辅助解决方案市场：按产品类型、阶段、最终用途和适应症分类 - 2025-2030 年全球预测

Clinical Trial Equipment & Ancillary Solutions Market by Product (Equipment, Services, Systems), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, End-Use, Indication - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年临床试验设备及辅助解决方案市场规模为42.1亿美元，预计2024年将达到45.8亿美元，复合年增长率为8.81%，2030年将达到76.2亿美元。

临床试验设备和辅助解决方案市场包括各种基本产品和服务，可确保合规性、效率、准确性并促进临床试验的进行。这包括医疗设备、监控设备、实验室用品以及资料管理软体和病患监测系统等 IT 解决方案。对这些解决方案的需求是由简化临床试验业务、提高资料完整性和增强病患安全的关键需求所驱动的。其应用涵盖临床试验的各个阶段，从患者招募和监测到资料收集和监管合规性。最终用户主要是製药公司、生技公司和代表申办者进行临床试验的 CRO（委外研发机构）。

主要市场统计
基准年[2023] 42.1亿美元
预测年份 [2024] 45.8亿美元
预测年份 [2030] 76.2亿美元
复合年增长率（%） 8.81%

该市场的关键成长要素包括由于研发投资增加而导致的临床试验量增加、临床试验的复杂性增加以及需要先进设备和解决方案的严格监管要求。此外，临床试验设备中的人工智慧和物联网整合等技术进步透过实现远端监控和增强即时资料分析提供了庞大的商机。由于成本优势和多样化的人群，临床试验活动不断扩大，新兴市场存在重大机会。建立本地伙伴关係和投资在地化技术解决方案是利用这些机会的建议策略。

然而，新兴市场面临高成本和与先进设备相关的基础设施不足等挑战，这可能会抑製成长。不断变化的法规以及频繁更新和检验设备的需要也是主要障碍。行动医疗技术、分散式测试和模组化测试解决方案的创新和研究是业务成长的有希望的领域，有可能克服现有的限制并回应不断变化的市场需求。总体而言，市场的特点是技术快速发展以及对临床试验准确性和效率的要求不断提高，公司需要具有适应性和前瞻性思维，以有效捕捉其成长潜力，并保持自己的方法极为重要。

市场动态：快速发展的临床试验设备和辅助解决方案市场的关键市场洞察

供需的动态交互作用正在改变临床试验设备和辅助解决方案市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 确定新药和医疗设备安全有效使用的需要
    • 全球临床试验活动外包
    • 增加临床试验设备和辅助解决方案研发活动的投资
  • 市场限制因素
    • 与云端基础的临床试验解决方案相关的资料安全风险
  • 市场机会
    • 政府对药物开发和临床试验的措施和支持
    • 将人工智慧 (AI) 和资料分析整合到临床试验解决方案中
  • 市场挑战
    • 临床试验跨境物流程序的复杂性

波特的五力：驾驭临床试验设备和辅助解决方案市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对临床试验设备和辅助解决方案市场的影响

外部宏观环境因素在塑造临床试验设备和辅助解决方案市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解临床试验设备和辅助解决方案市场的竞争格局

临床试验设备和辅助解决方案市场的详细市场占有率分析提供了对供应商绩效的全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵临床试验设备及辅助解决方案市场供应商绩效评估

FPNV 定位矩阵是评估临床试验设备和辅助解决方案市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 需要确定如何安全有效地使用新药品和医疗设备
      • 外包世界各地的临床试验活动
      • 增加临床试验设备和辅助解决方案研发活动的投资
    • 抑制因素
      • 与云端基础的临床试验解决方案相关的资料安全风险
    • 机会
      • 政府对药物开发和临床试验的措施和支持
      • 将人工智慧 (AI) 和资料分析整合到临床试验解决方案中
    • 任务
      • 临床试验跨境物流流程的复杂性
  • 市场区隔分析
    • 产品：在设备租赁和租赁服务中增加使用辅助采购服务
    • 类型：临床检测设备在生物药生产过程中的应用日益增多
    • 适应症：对分析胃肠道疾病的临床试验设备的需求不断增长
    • 阶段：II期增加使用临床试验设备和辅助解决方案来评估药物疗效
    • 最终用途：扩大临床试验设备在生技和製药公司的应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章临床试验设备与辅助解决方案市场：依产品

  • 装置
    • 诊断影像设备
    • 实验设备
  • 服务
    • 辅助采购服务
      • 设备租赁及出租服务
      • 采购
      • 供应和物流
    • 资料管理和分析服务
    • 维护和校准服务
    • 监理和合规服务
    • 现场监控与支援服务
    • 培训和咨询服务
  • 系统
    • 临床试验管理系统
    • 电子资料撷取系统
    • 随机化和临床实验供应管理

第七章临床试验设备和辅助解决方案市场：按类型

  • 生物製药
  • 医疗设备
  • 小分子

第八章临床试验设备及辅助解决方案市场分阶段状况

  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第九章临床试验设备与辅助解决方案市场：依最终用途分类

  • 学术研究所
  • 生物技术和製药公司
  • 合约调查机构
  • 医疗设备公司

第十章临床试验设备与辅助解决方案市场（按适应症）

  • 血液疾病
  • 心血管疾病
  • 中枢神经系统和精神障碍
  • 消化系统疾病
  • 免疫学
  • 感染疾病
  • 代谢紊乱
  • 肿瘤学

第十一章美洲临床试验设备及辅助解决方案市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太临床试验设备及辅助解决方案市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲临床试验设备及辅助解决方案市场

  • 丹麦
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • RQM+ 收购 Libra Medical
    • Lambda Therapeutics 与 Medidata 合作，实现资料管理流程自动化和简化，并提高临床试验效率。
    • Mednet 在 iMednet eClinical 平台中推出 DICOM 成像功能
    • Launch Therapeutics 选择 Medidata AI 智慧试验加速临床试验开发
    • Clinical ink 宣布与 Mural Health 建立策略合作伙伴关係，以提供新患者支付和物流能力
    • Cloudbyz 推出突破性电子资料撷取解决方案，以简化临床研究并加速新治疗方法的推出
    • Clario 发布用于临床试验的云端基础的影像检视器
    • ClinChoice 透过收购 CRO 继续扩张
    • Suvoda推出专用软体平台
    • Huma 收购 Arcedis 扩大临床试验平台
    • CardieX 子公司 ATCOR 与 Invariant 合作，利用先进的人工智慧医疗技术进行临床试验
    • RQM+推出临床试验服务
    • Edison Partners主导临床试验资讯中断公司 Locavant 的 2,100 万美元资金筹措
    • PAREXEL 在中国苏州开设临床试验用品和物流仓库
    • 飞利浦推出用于分散临床试验的 12 导程心电图解决方案

公司名单

  • Eurofins Scientific SE
  • Veeva Systems Inc.
  • Yokogawa Electric Corporation
  • United Parcel Service, Inc.
  • Thermo Fisher Scientific, Inc.
  • Quipment SAS
  • Emsere BV
  • Dassault Systemes SE
  • Parexel International Corporation
  • Lonza Group Ltd.
  • Global Vision Technologies, Inc.
  • Oracle Corporation
  • Charles River Laboratories International, Inc.
  • Axelerist
  • Zifo Technologies Private Limited
  • B. Braun SE
  • Bio-Rad Laboratories, Inc.
  • Eppendorf SE
  • IQVIA Holdings Inc.
  • Almac Group Limited
  • Navitas Inc.
  • Quanticate International Limited
  • Ancillare, LP
  • Royal Philips
  • MedNet Solutions, Inc.
  • Avantor, Inc.
  • Myonex, Inc.
  • Hitachi, Ltd.
Product Code: MRR-8C74ADFC1246

The Clinical Trial Equipment & Ancillary Solutions Market was valued at USD 4.21 billion in 2023, expected to reach USD 4.58 billion in 2024, and is projected to grow at a CAGR of 8.81%, to USD 7.62 billion by 2030.

The Clinical Trial Equipment & Ancillary Solutions market encompasses a variety of essential products and services that facilitate the execution of clinical studies, ensuring compliance, efficiency, and accuracy. This includes medical devices, monitoring equipment, lab supplies, and IT solutions such as software for data management and patient monitoring systems. The necessity of these solutions is driven by the critical need to streamline trial operations, improve data integrity, and enhance patient safety. Their application spans various phases of clinical trials, from patient recruitment and monitoring to data collection and regulatory compliance. End-use primarily involves pharmaceutical and biotechnology companies, along with Contract Research Organizations (CROs) that conduct clinical trials on behalf of sponsors.

KEY MARKET STATISTICS
Base Year [2023] USD 4.21 billion
Estimated Year [2024] USD 4.58 billion
Forecast Year [2030] USD 7.62 billion
CAGR (%) 8.81%

Key growth influencers in this market include the rise in clinical trial volume driven by increasing investments in R&D, the growing complexity of trials, and stringent regulatory requirements demanding advanced equipment and solutions. Additionally, technological advancements such as the integration of AI and IoT in clinical trial equipment present substantial opportunities, enabling remote monitoring and enhancing real-time data analysis. A prominent opportunity lies in emerging markets where clinical trial activity is expanding due to cost advantages and diverse populations. Establishing local partnerships and investing in localized technology solutions are recommended strategies to capitalize on these opportunities.

However, the market faces challenges such as high costs associated with advanced equipment and inadequate infrastructure in developing regions, which might impede growth. Regulatory changes and the need for frequent updates and validation of equipment also pose significant hurdles. Innovation and research in mobile health technologies, decentralized trials, and modular trial solutions are promising areas for business growth, offering potential to overcome existing limitations and cater to evolving market needs. Overall, the market is characterized by rapid technological evolution and increasing demand for precision and efficiency in clinical trials, making it crucial for businesses to stay adaptive and forward-thinking in their approach to capture the growth potential effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trial Equipment & Ancillary Solutions Market

The Clinical Trial Equipment & Ancillary Solutions Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need to determine the safe and effective use of new drugs and medical device
    • Outsourcing of clinical trial activity across the globe
    • Increasing investment in R&D activities for clinical trials equipment & ancillary solutions
  • Market Restraints
    • Data security risks associated with cloud-based clinical trial solutions
  • Market Opportunities
    • Government initiatives and support for drug development and clinical trials
    • Integration of artificial intelligence (AI) and data analytics in clinical trial solutions
  • Market Challenges
    • Complexities in procedures of cross border logistics for clinical trials

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trial Equipment & Ancillary Solutions Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trial Equipment & Ancillary Solutions Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trial Equipment & Ancillary Solutions Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trial Equipment & Ancillary Solutions Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trial Equipment & Ancillary Solutions Market

A detailed market share analysis in the Clinical Trial Equipment & Ancillary Solutions Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trial Equipment & Ancillary Solutions Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trial Equipment & Ancillary Solutions Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Equipment & Ancillary Solutions Market, highlighting leading vendors and their innovative profiles. These include Eurofins Scientific SE, Veeva Systems Inc., Yokogawa Electric Corporation, United Parcel Service, Inc., Thermo Fisher Scientific, Inc., Quipment SAS, Emsere B.V., Dassault Systemes SE, Parexel International Corporation, Lonza Group Ltd., Global Vision Technologies, Inc., Oracle Corporation, Charles River Laboratories International, Inc., Axelerist, Zifo Technologies Private Limited, B. Braun SE, Bio-Rad Laboratories, Inc., Eppendorf SE, IQVIA Holdings Inc., Almac Group Limited, Navitas Inc., Quanticate International Limited, Ancillare, LP, Royal Philips, MedNet Solutions, Inc., Avantor, Inc., Myonex, Inc., and Hitachi, Ltd..

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Equipment & Ancillary Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Equipment, Services, and Systems. The Equipment is further studied across Imaging & Diagnostic Equipment and Laboratory Equipment. The Services is further studied across Ancillary Sourcing Services, Data Management & Analysis Services, Maintenance & Calibration Services, Regulatory & Compliance Services, Site Monitoring & Support Services, and Training & Consulting Services. The Ancillary Sourcing Services is further studied across Equipment Leasing & Rental Services, Procurement, and Supply & Logistics. The Systems is further studied across Clinical Trial Management Systems, Electronic Data Capture Systems, and Randomization & Trial Supply Management.
  • Based on Type, market is studied across Biologic Drugs, Medical Devices, and Small Molecules.
  • Based on Phase, market is studied across Phase I, Phase II, Phase III, and Phase IV.
  • Based on End-Use, market is studied across Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Contract Research Organizations, and Medical Device Companies.
  • Based on Indication, market is studied across Blood Disorders, Cardiovascular Diseases, CNS & Mental Disorders, Digestive Disorders, Immunology, Infectious Diseases, Metabolic Disorders, and Oncology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Finland, France, Germany, Israel, Italy, Netherlands, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need to determine the safe and effective use of new drugs and medical device
      • 5.1.1.2. Outsourcing of clinical trial activity across the globe
      • 5.1.1.3. Increasing investment in R&D activities for clinical trials equipment & ancillary solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Data security risks associated with cloud-based clinical trial solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Government initiatives and support for drug development and clinical trials
      • 5.1.3.2. Integration of artificial intelligence (AI) and data analytics in clinical trial solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities in procedures of cross border logistics for clinical trials
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing utilization of ancillary sourcing services for equipment leasing & rental services
    • 5.2.2. Type: Increasing application of clinical trial equipment in the manufacturing process of biological drugs
    • 5.2.3. Indication: Rising preferences for clinical trial equipment to analyze digestive disorders
    • 5.2.4. Phase: Growing usage of clinical trial equipments & ancillary solutions in phase II to assess effectiveness of drug
    • 5.2.5. End-Use: Expanding application of clinical trial equipment in biotechnology & pharmaceutical companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Trial Equipment & Ancillary Solutions Market, by Product

  • 6.1. Introduction
  • 6.2. Equipment
    • 6.2.1. Imaging & Diagnostic Equipment
    • 6.2.2. Laboratory Equipment
  • 6.3. Services
    • 6.3.1. Ancillary Sourcing Services
      • 6.3.1.1. Equipment Leasing & Rental Services
      • 6.3.1.2. Procurement
      • 6.3.1.3. Supply & Logistics
    • 6.3.2. Data Management & Analysis Services
    • 6.3.3. Maintenance & Calibration Services
    • 6.3.4. Regulatory & Compliance Services
    • 6.3.5. Site Monitoring & Support Services
    • 6.3.6. Training & Consulting Services
  • 6.4. Systems
    • 6.4.1. Clinical Trial Management Systems
    • 6.4.2. Electronic Data Capture Systems
    • 6.4.3. Randomization & Trial Supply Management

7. Clinical Trial Equipment & Ancillary Solutions Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small Molecules

8. Clinical Trial Equipment & Ancillary Solutions Market, by Phase

  • 8.1. Introduction
  • 8.2. Phase I
  • 8.3. Phase II
  • 8.4. Phase III
  • 8.5. Phase IV

9. Clinical Trial Equipment & Ancillary Solutions Market, by End-Use

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Biotechnology & Pharmaceutical Companies
  • 9.4. Contract Research Organizations
  • 9.5. Medical Device Companies

10. Clinical Trial Equipment & Ancillary Solutions Market, by Indication

  • 10.1. Introduction
  • 10.2. Blood Disorders
  • 10.3. Cardiovascular Diseases
  • 10.4. CNS & Mental Disorders
  • 10.5. Digestive Disorders
  • 10.6. Immunology
  • 10.7. Infectious Diseases
  • 10.8. Metabolic Disorders
  • 10.9. Oncology

11. Americas Clinical Trial Equipment & Ancillary Solutions Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Finland
  • 13.4. France
  • 13.5. Germany
  • 13.6. Israel
  • 13.7. Italy
  • 13.8. Netherlands
  • 13.9. Norway
  • 13.10. Poland
  • 13.11. Qatar
  • 13.12. Russia
  • 13.13. Saudi Arabia
  • 13.14. South Africa
  • 13.15. Spain
  • 13.16. Sweden
  • 13.17. Switzerland
  • 13.18. United Arab Emirates
  • 13.19. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. RQM+ Acquires Libra Medical
    • 14.3.2. Lambda Therapeutics partners with Medidata to automate and streamline data management processes for greater clinical trial efficiency
    • 14.3.3. Mednet Launches DICOM Imaging Capabilities Within the iMednet eClinical Platform
    • 14.3.4. Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development
    • 14.3.5. Clinical ink Announces Strategic Partnership with Mural Health for New Patient Payment and Logistics Capabilities
    • 14.3.6. Cloudbyz Unveils Groundbreaking Electronic Data Capture Solution to Streamline Clinical Research and Accelerate Launch of New Therapies
    • 14.3.7. Clario Launches Cloud-Based Image Viewer for Clinical Trials
    • 14.3.8. ClinChoice continues expansion with CRO acquisition
    • 14.3.9. Suvoda launches purpose-built software platform
    • 14.3.10. Huma acquires Alcedis to expand clinical trial platform
    • 14.3.11. CardieX Subsidiary ATCOR Partners with Invaryant to Enable Clinical Trials with Advanced New AI Medical Technology
    • 14.3.12. RQM+ Launches Clinical Trial Services
    • 14.3.13. Edison Partners leads USD 21 million funding round for clinical trial intelligence disruptor Lokavant
    • 14.3.14. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
    • 14.3.15. Philips launches 12-lead ECG solution for decentralized clinical trials

Companies Mentioned

  • 1. Eurofins Scientific SE
  • 2. Veeva Systems Inc.
  • 3. Yokogawa Electric Corporation
  • 4. United Parcel Service, Inc.
  • 5. Thermo Fisher Scientific, Inc.
  • 6. Quipment SAS
  • 7. Emsere B.V.
  • 8. Dassault Systemes SE
  • 9. Parexel International Corporation
  • 10. Lonza Group Ltd.
  • 11. Global Vision Technologies, Inc.
  • 12. Oracle Corporation
  • 13. Charles River Laboratories International, Inc.
  • 14. Axelerist
  • 15. Zifo Technologies Private Limited
  • 16. B. Braun SE
  • 17. Bio-Rad Laboratories, Inc.
  • 18. Eppendorf SE
  • 19. IQVIA Holdings Inc.
  • 20. Almac Group Limited
  • 21. Navitas Inc.
  • 22. Quanticate International Limited
  • 23. Ancillare, LP
  • 24. Royal Philips
  • 25. MedNet Solutions, Inc.
  • 26. Avantor, Inc.
  • 27. Myonex, Inc.
  • 28. Hitachi, Ltd.

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMAGING & DIAGNOSTIC EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY LABORATORY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT LEASING & RENTAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PROCUREMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY & LOGISTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DATA MANAGEMENT & ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MAINTENANCE & CALIBRATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGULATORY & COMPLIANCE SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SITE MONITORING & SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ELECTRONIC DATA CAPTURE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY RANDOMIZATION & TRIAL SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 176. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 184. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 186. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 192. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 193. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 194. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 195. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 201. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 202. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 204. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 206. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 207. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 210. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 211. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 212. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 213. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 215. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 216. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 219. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 220. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 221. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 222. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 224. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 225. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 238. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 239. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 240. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 241. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 243. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 244. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS